Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Naltrexone and nicotine patch smoking cessation: a preliminary study.

Krishnan-Sarin S, Meandzija B, O'Malley S.

Nicotine Tob Res. 2003 Dec;5(6):851-7.

PMID:
14750508
2.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
3.

Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review.

Le Houezec J.

Int J Tuberc Lung Dis. 2003 Sep;7(9):811-9. Review.

PMID:
12971663
4.

Clinical inquiries. What is the most effective nicotine replacement therapy?

Diefenbacher LJ, Smith PO, Nashelsky J, Lindbloom E.

J Fam Pract. 2003 Jun;52(6):492-4. Review. No abstract available.

PMID:
12791233
5.

Sex differences in long-term smoking cessation rates due to nicotine patch.

Perkins KA, Scott J.

Nicotine Tob Res. 2008 Jul;10(7):1245-50. doi: 10.1080/14622200802097506. Review.

PMID:
18629735
6.

The benefits of stopping smoking and the role of nicotine replacement therapy in older patients.

Gourlay SG, Benowitz NL.

Drugs Aging. 1996 Jul;9(1):8-23. Review.

PMID:
8818582
7.

Nicotine replacement therapy.

Fant RV, Owen LL, Henningfield JE.

Prim Care. 1999 Sep;26(3):633-52. Review.

PMID:
10436291
8.

Current approaches in smoking cessation.

Skaar K, Tsoh J, Cinciripini P, Wetter D, Prokhorov A, Gritz E.

Curr Opin Oncol. 1996 Sep;8(5):434-40. Review.

PMID:
8914811
9.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
10.

The impact of smoking cessation on objective and subjective markers of sleep: review, synthesis, and recommendations.

Colrain IM, Trinder J, Swan GE.

Nicotine Tob Res. 2004 Dec;6(6):913-25. Review.

PMID:
15801567
11.

Pharmacotherapy for smoking cessation during pregnancy.

Benowitz N, Dempsey D.

Nicotine Tob Res. 2004 Apr;6 Suppl 2:S189-202. Review. No abstract available.

PMID:
15203821
12.

Systematic review and meta-analysis of opioid antagonists for smoking cessation.

David SP, Chu IM, Lancaster T, Stead LF, Evins AE, Prochaska JJ.

BMJ Open. 2014 Mar 14;4(3):e004393. doi: 10.1136/bmjopen-2013-004393. Review.

13.

[Limited role of naltrexone in the treatment of opiate addiction].

van Brussel GH.

Ned Tijdschr Geneeskd. 2001 Jul 28;145(30):1452-6. Review. Dutch.

PMID:
11503313
14.
15.

Prescribing nicotine substitutes for tobacco cessation: considerations and contraindications.

Salinas TJ, Jacob RF.

Tex Dent J. 1994 Jun;111(6):33-5, 37. Review.

PMID:
8633292
16.

Clinical uses of naltrexone: a review of the evidence.

Modesto-Lowe V, Van Kirk J.

Exp Clin Psychopharmacol. 2002 Aug;10(3):213-27. Review.

PMID:
12233982
17.

Placebo effects of tobacco smoking and other nicotine intake.

Perkins K, Sayette M, Conklin C, Caggiula A.

Nicotine Tob Res. 2003 Oct;5(5):695-709. Review. Erratum in: Nicotine Tob Res. 2004 Jun;6(3):575.

PMID:
14577986
18.

Nicotine replacement therapy.

Molyneux A.

BMJ. 2004 Feb 21;328(7437):454-6. Review. No abstract available. Erratum in: BMJ. 2004 Mar 20;328(7441):686.

19.

Smoking tobacco, microcirculatory changes and the role of nicotine.

Haustein KO.

Int J Clin Pharmacol Ther. 1999 Feb;37(2):76-85. Review. No abstract available.

PMID:
10082171
20.

[Substitution therapy in drug addictions].

Auriacombe M, Fatseas M, Franques-Rénéric P, Daulouède JP, Tignol J.

Rev Prat. 2003 Jun 15;53(12):1327-34. Review. French.

PMID:
12920942
Items per page

Supplemental Content

Write to the Help Desk